Schilddrüsendiagnostik in der guten klinischen Praxis

Zusammenfassung

Im klinischen nuklearmedizinischen Alltag in Deutschland stellt die Diagnostik und Behandlung von Schilddrüsenerkrankungen eine der häufigsten Tätigkeit des Facharztes dar, vor allem im niedergelassenen Bereich. Die Deutsche Gesellschaft für Nuklearmedizin (DGN) hat seit Jahren eine klare Leitlinie zur Schilddrüsendiagnostik bereitgestellt. In diesem Beitrag wird die Leitlinie auf die wichtigsten Punkte zusammengefasst, offene Fragen angesprochen und die Leitlinie mit neuen Erkenntnissen aus den letzten Jahren kommentiert.

Abstract

The diagnosis and treatment of thyroid diseases represents the most common clinical activity of the German nuclear medicine specialist, especially in out-patient practice. The German Society of Nuclear Medicine (DGN) has made a clear guideline available for the diagnosis of thyroid diseases. In this article we have summarized the most important aspects of the guideline, pointed out open questions and commented the guideline with new insights from recent literature.

Schlüsselwörter

Schilddrüse - Szintigrafie - Diagnostik

Key words

thyroid - scintigraphy - diagnostics

• Literatur

• 1 AACE/AME Task Force on Thyroid Nodules . American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006; 12: 63-102
• 2 Andermann P, Schlogl S, Mader U et al. Intra- and interobserver variability of thyroid volume measurements in healthy adults by 2D versus 3D ultrasound. Nuklearmedizin 2007; 46: 1-7
• 3 Börner W, Lautsch M, Moll E et al. Die diagnostische Bedeutung des „kalten Knotens“ im Schilddrüsenszintigramm. Med Welt 1965; 17: 892-897
• 4 Casara D, Rubello D, Saladini G. Role of scintigraphy with tumor-seeking agents in the diagnosis and preoperative staging of malignant thyroid nodules. Biomed Pharmacother 2000; 54: 334-336
• 5 Cohen MS, Arslan N, Dehdashti F et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130: 941-946
• 6 Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214
• 7 Dietlein M, Dressler J, Eschner W et al. Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3). Nuklearmedizin 2007; 46: 213-219
• 8 Dietlein M, Dressler J, Eschner W et al. Verfahrensanweisung für die Schilddrüsenszintigraphie (Version 3). Deutsche Gesellschaft für Nuklearmedizin 2007; Ref Type: Abstract
• 9 Dietlein M, Dressler J, Grünwald F et al. Leitlinie zur Schilddrüsendiagnostik. Deutsche Gesellschaft für Nuklearmedizin 2003;
• 10 Frates MC, Benson CB, Charboneau JW et al. Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology 2005; 237: 794-800
• 11 Giovanella L, Suriano S, Maffioli M et al. 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology. Clin Endocrinol (Oxf) 2011; 74: 644-648
• 12 Hegedus L, Karstrup S. Ultrasonography in the evaluation of cold thyroid nodules. Eur J Endocrinol 1998; 138: 30-31
• 13 Hocevar M, Auersperg M. Role of thyroglobulin in the pre-operative evaluation of follicular thyroid tumours. Eur J Surg Oncol 1997; 24: 553-557
• 14 Karges W, Dralle H, Raue F et al. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: . German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004; 112: 52-58
• 15 Klemenz B, Wieler H, Kaiser HP. Value of color-coded doppler sonography in the differential diagnosis of thyroid nodules. Nuklearmedizin 1997; 36: 245-249
• 16 Lyshchik AP, Higashi T, Asato R et al. Thyroid gland tumor diagnosis at US elastography. Radiology 2005; 237: 202-211
• 17 Rago T, Santini M, Scutari A et al. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab 2007; 92: 2917-2922
• 18 Rago T, Vitti P. Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules. Best Pract Clin Endocrinol Metab 2008; 22: 913-928
• 19 Raue F. Routine calcitonin determination in thyroid nodules – an effective approach?. Exp Clin Endocrinol Diabetes 1998; 106: 289-291
• 20 Reiners C, Wegscheider K, Schicha H et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96 278 unselected employees. Thyroid 2004; 14: 926-932
• 21 Saggiorato E, Angusti T, Rosas R et al. ^99 mTc-MIBI imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidruf resistance protein expression. J Nucl Med 2009; 50: 1785-1793
• 22 Schicha H, Hellmich M, Lehmacher W et al. Should all patients with thyroid nodules>or=1 cm undergo fine-needle aspiration biopsy?. Nuklearmedizin 2009; 48: 79-83
• 23 Schlogl S, Werner E, Lassmann M et al. The use of three-dimensional ultrasound for thyroid volumetry. Thyroid 2001; 11: 569-574
• 24 Vierhapper H, Raber W, Bieglmayer C et al. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 1997; 82: 1589-1593
• 25 Wiedemann W, Reiners C. Die differentialdiagnose des echoarmen Knotens der Schilddrüse. Dtsch Med Wochenschr 1982; 51: 1972-1975